YONGAN PHARMACEUTICAL: The price of taurine stopped falling in May and began to rebound, but the price increase is a gradual process
On July 16th, YONGAN PHARMACEUTICAL stated on the interactive platform that the price of taurine, after experiencing a three-year adjustment, stopped falling and began to rebound in May of this year. However, the price increase is a gradual process. According to the company's semi-annual performance forecast for 2025, the company's performance in the first half of the year has significantly declined compared to the same period last year, mainly due to the impact of a sluggish market, resulting in a decrease in both the production and sales volume and sales price of the company's main product, taurine, compared to the same period last year
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments